Publications by authors named "Seth Hetherington"

Claim this Profile
T
Therapeutic HSV-2 vaccine decreases recurrent virus shedding and recurrent genital herpes disease.
David I Bernstein, Jessica B Flechtner, Lisa K McNeil, Thomas Heineman, Tom Oliphant, Seth Hetherington

Vaccine· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Different Doses of GEN-003, a Therapeutic Vaccine for Genital Herpes Simplex Virus-2, on Viral Shedding and Lesions: Results of a Randomized Placebo-Controlled Trial.
Nicholas Van Wagoner, Kenneth Fife, Peter A Leone, David I Bernstein, Terri Warren, Seth Hetherington

J Infect Dis· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Vaccine for Genital Herpes Simplex Virus-2 Infection: Findings From a Randomized Trial.
David I Bernstein, Anna Wald, Terri Warren, Kenneth Fife, Stephen Tyring, Seth Hetherington

J Infect Dis· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune responses elicited by the GEN-003 candidate HSV-2 therapeutic vaccine in a randomized controlled dose-ranging phase 1/2a trial.
Jessica Baker Flechtner, Deborah Long, Shane Larson, Veronica Clemens, Amy Baccari, Seth Hetherington

Vaccine· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluconazole prophylaxis in preterm infants: a multicenter case-controlled analysis of efficacy and safety.
David A Kaufman, Amy Morris, Matt J Gurka, Barry Kapik, Seth Hetherington

Early Hum Dev· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kv7 potassium channel activation with ICA-105665 reduces photoparoxysmal EEG responses in patients with epilepsy.
Dorotheé G A Kasteleijn-Nolst Trenité, Victor Biton, Jacqueline A French, Bassel Abou-Khalil, William E Rosenfeld, Seth V Hetherington

Epilepsia· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COMMENTARY: understanding the benefits of pediatric anti-retroviral treatment in resource-limited settings.
Seth Hetherington

Pediatr Infect Dis J· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical trial of safety and efficacy of INH-A21 for the prevention of nosocomial staphylococcal bloodstream infection in premature infants.
Mitchell DeJonge, David Burchfield, Barry Bloom, Maria Duenas, Whit Walker, Seth Hetherington

J Pediatr· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I dose escalation study to evaluate the safety and pharmacokinetic profile of tefibazumab in subjects with end-stage renal disease requiring hemodialysis.
Seth Hetherington, Michele Texter, Eric Wenzel, Joseph M Patti, Laurie Reynolds

Antimicrob Agents Chemother· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II, randomized, double-blind, multicenter study comparing the safety and pharmacokinetics of tefibazumab to placebo for treatment of Staphylococcus aureus bacteremia.
J John Weems, James P Steinberg, Scott Filler, John W Baddley, G Ralph Corey, Seth Hetherington

Antimicrob Agents Chemother· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter study to determine antibody concentrations and assess the safety of administration of INH-A21, a donor-selected human Staphylococcal immune globulin, in low-birth-weight infants.
Edmund V Capparelli, Barry T Bloom, Tom J Kueser, David G Oelberg, Ellen M Bifano, Seth V Hetherington

Antimicrob Agents Chemother· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter study to assess safety and efficacy of INH-A21, a donor-selected human staphylococcal immunoglobulin, for prevention of nosocomial infections in very low birth weight infants.
Barry Bloom, Robert Schelonka, Tom Kueser, Whit Walker, Elizabeth Jung, Seth Hetherington

Pediatr Infect Dis J· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Open-label, dose escalation study of the safety and pharmacokinetic profile of tefibazumab in healthy volunteers.
Sandra Reilley, Eric Wenzel, Laurie Reynolds, Beth Bennett, Joseph M Patti, Seth Hetherington

Antimicrob Agents Chemother· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiviral efficacy of abacavir in antiretroviral therapy-experienced adults harbouring HIV-1 with specific patterns of resistance to nucleoside reverse transcriptase inhibitors.
E Randall Lanier, Mounir Ait-Khaled, Janna Scott, Chris Stone, Thomas Melby, Seth Hetherington

Antivir Ther· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of symptoms of influenza A with abacavir-associated hypersensitivity reaction.
Philip Keiser, Naiel Nassar, Daniel Skiest, Charla Andrews, Beena Yazdani, Seth Hetherington

Int J STD AIDS· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of combination antiretroviral therapy on cerebrospinal fluid HIV RNA, HIV resistance, and clinical manifestations of encephalopathy.
Cynthia McCoig, Maria Mercedes Castrejón, Elizabeth Castaño, Onix De Suman, Carmen Báez, Seth Hetherington

J Pediatr· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factor analysis of hypersensitivity reactions to abacavir.
William Symonds, Amy Cutrell, Mark Edwards, Helen Steel, Bill Spreen, Seth Hetherington

Clin Ther· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic variations in HLA-B region and hypersensitivity reactions to abacavir.
Seth Hetherington, Arlene R Hughes, Michael Mosteller, Denise Shortino, Katherine L Baker

Lancet· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abacavir expanded access program for adult patients infected with human immunodeficiency virus type 1.
Harold A Kessler, Judy Johnson, Stephen Follansbee, Michael G Sension, Donna Mildvan, Seth V Hetherington

Clin Infect Dis· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis